SlideShare uma empresa Scribd logo
1 de 5
Genzyme Corporation
Presented By
Prachi Mule
Vishal Pareek
Sarith Somasundaran
Gourav Nagar
Genzyme's Profile
Type:

Public

Industry:

Biotechnology

Founded:

1981

Products:

Cerezyme

Revenue:

(US $3.1 Billion) (2006)

Employees: over 8000
Product():

25

Location:

25(Multinational)
Success Story
› Unique Strategy
“Target small market of rare diseases”
› Business Model
“High-Risk, High-Reward”
› Orphan Drug Act - 1983
› Innovative initial marketing strategy to save cost
› First big success - Ceredase
Problems Faced
› Possible failures
– Eg: Orphan Drug Act

› Failure to realize weaknesses
› Management too rigid

› Need to maintain total control
Recommendations
› Partnerships to reduce manufacturing and sales cost

› Increase focus on marketing
› Management should be flexible
› Explore new opportunities to adapt to market dynamics

› Leverage the brand name to diversify operation

Mais conteúdo relacionado

Semelhante a Genzyme

Creativity and Performance
Creativity and PerformanceCreativity and Performance
Creativity and PerformanceJean-Michel Peny
 
Smart Pharma Consulting 1, rue Houdart de Lamotte – 75015
Smart Pharma Consulting 1, rue Houdart de Lamotte – 75015 Smart Pharma Consulting 1, rue Houdart de Lamotte – 75015
Smart Pharma Consulting 1, rue Houdart de Lamotte – 75015 WilheminaRossi174
 
The future of the generc pharma industry & how it impacts business today
The future of the generc pharma industry & how it impacts business todayThe future of the generc pharma industry & how it impacts business today
The future of the generc pharma industry & how it impacts business today✪ Asa Cox (ThePharmaPartner)
 
Stock Pick: Dis-Chem1 by Jessica Brownhill
Stock Pick: Dis-Chem1 by Jessica BrownhillStock Pick: Dis-Chem1 by Jessica Brownhill
Stock Pick: Dis-Chem1 by Jessica BrownhillSTANLIB
 
Competitiveness and GlobalizationChapter 1Strategic Manageme.docx
Competitiveness and GlobalizationChapter 1Strategic Manageme.docxCompetitiveness and GlobalizationChapter 1Strategic Manageme.docx
Competitiveness and GlobalizationChapter 1Strategic Manageme.docxmaxinesmith73660
 
E4P CEMA16 SA Brochure v26
E4P CEMA16 SA Brochure v26E4P CEMA16 SA Brochure v26
E4P CEMA16 SA Brochure v26Giselle Quartin
 
Ilsi biomed abstract submission the new biotech business model 3 13
Ilsi biomed abstract submission the new biotech business model 3 13Ilsi biomed abstract submission the new biotech business model 3 13
Ilsi biomed abstract submission the new biotech business model 3 13Howard Sterling
 
Parkville strategic project final-converted
Parkville   strategic project final-convertedParkville   strategic project final-converted
Parkville strategic project final-convertedMohamed Ahmed
 
Strategy-Course-Notes+(1).pdf
Strategy-Course-Notes+(1).pdfStrategy-Course-Notes+(1).pdf
Strategy-Course-Notes+(1).pdfRayFang8
 
Case Study Analysis on GlaxoSmithkline
Case Study Analysis on GlaxoSmithklineCase Study Analysis on GlaxoSmithkline
Case Study Analysis on GlaxoSmithklineAanchal Saxena
 
emerging markets four entry strategies for small
emerging markets four entry strategies for smallemerging markets four entry strategies for small
emerging markets four entry strategies for smallVangelis Tryfonidis
 
Shared Value in the Pharmaceutical Industry
Shared Value in the Pharmaceutical IndustryShared Value in the Pharmaceutical Industry
Shared Value in the Pharmaceutical IndustryRobert Au
 
Pharma product launches
Pharma product launchesPharma product launches
Pharma product launchespranaliparab
 
BioEntrepreneurship: Life Science Business Models
BioEntrepreneurship: Life Science Business ModelsBioEntrepreneurship: Life Science Business Models
BioEntrepreneurship: Life Science Business ModelsMaRS Discovery District
 
Sm Case Jisha & Remya(2)
Sm Case Jisha & Remya(2)Sm Case Jisha & Remya(2)
Sm Case Jisha & Remya(2)guest78d8ca
 
DEFINING YOUR PLAYFIELDStudent NameAcadem
DEFINING YOUR PLAYFIELDStudent NameAcademDEFINING YOUR PLAYFIELDStudent NameAcadem
DEFINING YOUR PLAYFIELDStudent NameAcademLinaCovington707
 

Semelhante a Genzyme (20)

Creativity and Performance
Creativity and PerformanceCreativity and Performance
Creativity and Performance
 
Smart Pharma Consulting 1, rue Houdart de Lamotte – 75015
Smart Pharma Consulting 1, rue Houdart de Lamotte – 75015 Smart Pharma Consulting 1, rue Houdart de Lamotte – 75015
Smart Pharma Consulting 1, rue Houdart de Lamotte – 75015
 
The future of the generc pharma industry & how it impacts business today
The future of the generc pharma industry & how it impacts business todayThe future of the generc pharma industry & how it impacts business today
The future of the generc pharma industry & how it impacts business today
 
Stock Pick: Dis-Chem1 by Jessica Brownhill
Stock Pick: Dis-Chem1 by Jessica BrownhillStock Pick: Dis-Chem1 by Jessica Brownhill
Stock Pick: Dis-Chem1 by Jessica Brownhill
 
Competitiveness and GlobalizationChapter 1Strategic Manageme.docx
Competitiveness and GlobalizationChapter 1Strategic Manageme.docxCompetitiveness and GlobalizationChapter 1Strategic Manageme.docx
Competitiveness and GlobalizationChapter 1Strategic Manageme.docx
 
E4P CEMA16 SA Brochure v26
E4P CEMA16 SA Brochure v26E4P CEMA16 SA Brochure v26
E4P CEMA16 SA Brochure v26
 
Ilsi biomed abstract submission the new biotech business model 3 13
Ilsi biomed abstract submission the new biotech business model 3 13Ilsi biomed abstract submission the new biotech business model 3 13
Ilsi biomed abstract submission the new biotech business model 3 13
 
Parkville strategic project final-converted
Parkville   strategic project final-convertedParkville   strategic project final-converted
Parkville strategic project final-converted
 
Iran diabetes market study
Iran diabetes market studyIran diabetes market study
Iran diabetes market study
 
Differentiation strategies for the generic industrry
Differentiation strategies for the generic industrryDifferentiation strategies for the generic industrry
Differentiation strategies for the generic industrry
 
Strategy-Course-Notes+(1).pdf
Strategy-Course-Notes+(1).pdfStrategy-Course-Notes+(1).pdf
Strategy-Course-Notes+(1).pdf
 
Case Study Analysis on GlaxoSmithkline
Case Study Analysis on GlaxoSmithklineCase Study Analysis on GlaxoSmithkline
Case Study Analysis on GlaxoSmithkline
 
emerging markets four entry strategies for small
emerging markets four entry strategies for smallemerging markets four entry strategies for small
emerging markets four entry strategies for small
 
Shared Value in the Pharmaceutical Industry
Shared Value in the Pharmaceutical IndustryShared Value in the Pharmaceutical Industry
Shared Value in the Pharmaceutical Industry
 
The Future of the Pharmaceutical Industry in Spain
The Future of the Pharmaceutical Industry in SpainThe Future of the Pharmaceutical Industry in Spain
The Future of the Pharmaceutical Industry in Spain
 
Pharma product launches
Pharma product launchesPharma product launches
Pharma product launches
 
PPT (2).pptx
PPT (2).pptxPPT (2).pptx
PPT (2).pptx
 
BioEntrepreneurship: Life Science Business Models
BioEntrepreneurship: Life Science Business ModelsBioEntrepreneurship: Life Science Business Models
BioEntrepreneurship: Life Science Business Models
 
Sm Case Jisha & Remya(2)
Sm Case Jisha & Remya(2)Sm Case Jisha & Remya(2)
Sm Case Jisha & Remya(2)
 
DEFINING YOUR PLAYFIELDStudent NameAcadem
DEFINING YOUR PLAYFIELDStudent NameAcademDEFINING YOUR PLAYFIELDStudent NameAcadem
DEFINING YOUR PLAYFIELDStudent NameAcadem
 

Mais de Gourav Nagar

Technology Commercialization : Impact Resistant Glass
Technology Commercialization : Impact Resistant GlassTechnology Commercialization : Impact Resistant Glass
Technology Commercialization : Impact Resistant GlassGourav Nagar
 
Panic companion- Windows Phone App
Panic companion- Windows Phone AppPanic companion- Windows Phone App
Panic companion- Windows Phone AppGourav Nagar
 
Cool vendor presentation (2)
Cool vendor presentation (2)Cool vendor presentation (2)
Cool vendor presentation (2)Gourav Nagar
 
Data Warehouse Presentation
Data Warehouse PresentationData Warehouse Presentation
Data Warehouse PresentationGourav Nagar
 
BBC WorldWide IT Strategy
BBC WorldWide IT StrategyBBC WorldWide IT Strategy
BBC WorldWide IT StrategyGourav Nagar
 
Google || Corporate Strategy Planning Presentation
Google || Corporate Strategy Planning Presentation Google || Corporate Strategy Planning Presentation
Google || Corporate Strategy Planning Presentation Gourav Nagar
 

Mais de Gourav Nagar (7)

Technology Commercialization : Impact Resistant Glass
Technology Commercialization : Impact Resistant GlassTechnology Commercialization : Impact Resistant Glass
Technology Commercialization : Impact Resistant Glass
 
Panic companion- Windows Phone App
Panic companion- Windows Phone AppPanic companion- Windows Phone App
Panic companion- Windows Phone App
 
Data services
Data servicesData services
Data services
 
Cool vendor presentation (2)
Cool vendor presentation (2)Cool vendor presentation (2)
Cool vendor presentation (2)
 
Data Warehouse Presentation
Data Warehouse PresentationData Warehouse Presentation
Data Warehouse Presentation
 
BBC WorldWide IT Strategy
BBC WorldWide IT StrategyBBC WorldWide IT Strategy
BBC WorldWide IT Strategy
 
Google || Corporate Strategy Planning Presentation
Google || Corporate Strategy Planning Presentation Google || Corporate Strategy Planning Presentation
Google || Corporate Strategy Planning Presentation
 

Genzyme